Log on / register
BioMed Central home
|
Journals A-Z
|
Feedback
|
Support
|
My details
Home
|
Browse articles
|
Supplements
|
Series
|
Search
|
Weblinks
|
Submit article
|
My Malaria Journal
|
About Malaria Journal
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies.
Cohen JM, Singh I, O'Brien ME
Malar J
2008,
7
:200
[
Full text
]
[
PubMed
]
[
Related articles
]
[
Cited on BioMed Central
]
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
by date
by relevance
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
BioMed Central articles that cite the above article:
1.
Commentary
Drug procurement, the Global Fund and misguided competition policies
Tren R, Hess K, Bate R
Malaria Journal
2009,
8
:305
(22 December 2009)
[
Abstract
]
[
Full Text
]
[
PDF
]
[
PubMed
]
[
Related articles
]
2.
Minireview
The future of artemisinins: natural, synthetic or recombinant?
Hommel M
Journal of Biology
2008,
7
:38
(15 December 2008)
[
Abstract
]
[
Full text
]
[
PDF
]
[
PubMed
]
[
Related articles
]
You can also
check ISI Web of Science
for additional citations (subscription required)
printer friendly
20 per page
50 per page
200 per page
500 per page
selected items
abstract
no abstract
any time period
7 Days
14 Days
30 Days
60 Days
90 Days
180 Days
1 Year
by date
by relevance
all 2 results
this page
selected items
to
Endnote (no abstracts)
Endnote + abstracts
Ref. Manager (no abstracts)
Ref. Manager + abstracts
RefWorks (no abstracts)
RefWorks + abstracts
BibTeX (no abstracts)
BibTeX + abstracts
ProCite (no abstracts)
ProCite + abstracts
[
Help
]
Terms and Conditions
Privacy statement
Information for advertisers
Jobs at BMC
Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of
Springer Science+Business Media
.